JP Patent

JP7651048B1 — 固形組成物

Assigned to Daiichi Sankyo Healthcare Co Ltd · Expires 2025-03-25 · 1y expired

What this patent protects

【課題】固形組成物の提供。【解決手段】本発明は、イブプロフェンとトラネキサム酸からなる結晶と、界面活性剤と、を含む、固形組成物、を提供する。【選択図】なし

USPTO Abstract

【課題】固形組成物の提供。【解決手段】本発明は、イブプロフェンとトラネキサム酸からなる結晶と、界面活性剤と、を含む、固形組成物、を提供する。【選択図】なし

Drugs covered by this patent

Mobic (MELOXICAM) · Boehringer Ingelheim

Patent Metadata

Patent number: JP7651048B1
Jurisdiction: JP
Classification: —
Expires: 2025-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Healthcare Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.